// App-Quantinova.ai

553 : First Glimpse on Real-World Efficacy Outcomes for 2000 Patients with Systemic Light Chain Amyloidosis in Europe: A Retrospective Observational Multicenter Study By the European Myeloma Network

Researchers

Presenter

  • Giovanni Palladini

Principal Investigators

  • Stefan Schnland

  • Giampaolo Merlini

  • Paolo Milani

  • Arnaud Jaccard

  • Frank Bridoux

  • Wilfried Roeloffzen

  • M. Teresa Cibeira

  • Hermine Agis

  • Monique C. Minnema

  • Rui Bergantim

  • Roman Hajek

  • Cristina Joao

  • Ashutosh D. Wechalekar

  • Pieter Sonneveld

  • Efstathios Kastritis

Medical Centers

  • Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy

  • Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  • National Amyloidosis Center and Hematology Unit,CHU Limoges,Limoges,Francia

  • Hematology, CHU de Poitiers, Poitiers, France

  • Amyloidosis Centre of Expertise Department of Internal Medicine, Faculty of Medical Sciences,, University Medical Center Groningen, Groningen, Netherlands

  • Amyloidosis and Myeloma Unit, Department of Hematology,Hospital Clinic, IDIBAPS,Barcelona,Espagne

  • Department for Medicine I/Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria

  • Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

  • Departament of Urology, Hospital Sao Joao, Porto, Portugal

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • Hematology Department,Champalimaud Center for the Unknown,Lisbon,Portogallo

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Locations

  • Italy

  • Germany

  • France

  • Netherlands

  • Spain

  • Austria

  • Portugal

  • Czech Republic

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved